BioArctic AB
Short position disclosed on July 6, 2026.
0.59% of the capital sold short
1 disclosing funds
201 disclosures on record
SE0010323311 ISIN code
Evolution of the disclosed total
0%0.5%1%1.5%
Oct 2025Jan 2026Apr 2026Jul 2026
September 3, 2018 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Connor Clark & Lunn Investment Management Ltd. | 0.59% | +0.09 pt | July 6, 2026 |
On the other side: the funds that hold BioArctic AB Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| September 3, 2018 | Marshall Wace LLP | 0.52% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.36% of the capital sold short
- Elekta AB (publ) 10.19% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Bonesupport Holding AB 5.58% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Embracer Group AB 5.25% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- Dynavox Group AB 4.30% of the capital sold short
- RaySearch Laboratories AB (publ) 4.15% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, BioArctic AB, source Finansinspektionen, data as at July 6, 2026, https://www.quivad.com/action/bioarctic-ab?page=5